NDASA Member

Painting an accurate depiction of drug testing 2024 is artful by design but riddled with hills and valleys which represent the challenges that are currently facing the industry as a whole. Whether it be the ever-changing marijuana state laws, to collection site issues due to staffing shortages or the emergence of Oral fluid with the DOT rule change many are not sure if they are looking at a DaVinci or Picaso. This is an informative yet humorous discussion of what we face in the industry and how we can navigate the new landscape.